Y Mabs Therapeutics Inc (YMAB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Y Mabs Therapeutics Inc-Aktie (YMAB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.60% 19.52	20.90	26.50	18.46	22.80
Cost Of Revenue	11.30% 2.662	3.001	7.642	2.248	3.014
Gross Profit	5.81% 16.86	17.90	18.85	16.21	19.78
Operating Expenses	8.10% 22.47	24.45	24.79	24.78	29.57
Benefits Costs and Expenses	12.79% 22.76	26.09	34.04	25.11	31.95
Costs And Expenses	8.10% 22.47	24.45	17.43	27.03	32.59
Operating Income/Loss	14.35% -5.604	-6.543	-5.936	-8.568	-9.789
Income/Loss From Continuing Operations Before Tax	37.74% -3.232	-5.191	-7.542	-6.652	-9.149
Income Tax Expense/Benefit, Current	40.00% 0.007	0.005	-0.752	0.346	0.10
Income Tax Expense/Benefit, Deferred	-	-	-	-	-
Income Tax Expense/Benefit	40.00% 0.007	0.005	-0.752	0.346	0.10
Income/Loss From Continuing Operations After Tax	37.66% -3.239	-5.196	-6.79	-6.998	-9.249
Net Income/Loss	37.66% -3.239	-5.196	-6.79	-6.998	-9.249
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.47% 45.32	45.10	0.1838	44.63	44.02
Diluted Average Shares	0.47% 45.32	45.10	0.1838	44.63	44.02
Basic Earnings Per Share	41.67% -0.07	-0.12	-0.15	-0.16	-0.21
Diluted Earnings Per Share	41.67% -0.07	-0.12	-0.15	-0.16	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.65

1.18%

GMAB

$27.55

0.26%

SMMT

$25.99

9.45%

BNTX

$112.44

8.70%

INSM

$145.10

1.45%

ONC

$341.92

7.12%